Lung cancer ‘breath test’ to undergo trials


Lung cancer ‘breath test’ to undergo trials

A revolutionary breath test which could be used to detect lung cancer is to undergo clinical trials in NHS hospitals.

Owlstone – a spin-off from Cambridge University – has developed the Lung Cancer Indicator Detection (LuCID) device to detect chemical traces in breath which indicate a patient may have cancer.

Billy Boyle, co-founder of the firm, told Sky News a handheld device could be made available to GPs within two years.

He said he began to look at medical applications of the company’s technology, originally intended to detect explosives, when his wife Kate Gross was diagnosed with colon cancer two years ago before she died at 36 on Christmas Day.

Mr Boyle said: “The human body makes chemicals, a lot of them are just normal, everyday chemicals, but with cancer and other diseases the cells go a bit wrong and start to make chemicals differently. So by programming the chips in software to look for these different characteristic signatures and chemical markers you can programme it to look for a range of different diseases.

“We already have the microchip, we’re working on small handheld devices in [a] GP’s office. It’s important to get the clinical evidence first but we think we can have systems available, proven, within the next two years.

“And our goal is to save the NHS £245m – but more importantly to save 10,000 lives.”

Mr Boyle added he hoped the technology would lead to earlier detection of lung cancer, which kills more than 35,000 annually in the UK and has a low survival rate because diagnosis is often at the terminal stage.

The firm, which was awarded £1m in funding from NHS England’s Small Business Research Initiative for Healthcare, is to run trials at Glenfied Hospital in Leicester and one other. A desktop version of the “breathalyser” already exists and will be used in the clinical trials.

Dr Jonathan Bennett, a consultant at the hospital, told Sky News the test could be installed at GP surgeries and pharmacies if it proved successful and could be a “game-changer”.

Last year researchers, including a team from the University of Liverpool, discovered subtle genetic changes in vapour given off by cells that suggested a diagnostic breath test for lung cancer was theoretically possible.


source: standard/picture: Corbis

© No part of this web site may be reproduced without written permission from the publishers. All rights reserved. Todos los derechos reservados.


Please enter your comment!
Please enter your name here

We welcome comments from readers on our website and across our social networks. We invite you to discuss issues and share your views and we encourage robust debate and criticism provided it is civil.

However we reserve the right to reject or edit comments that:

• Contain offensive language
• Include personal attacks of any kind
• Are likely to offend or target any ethnic, racial, nationality or religious group
• Are homophobic, transphobic, sexist, offensive or obscene
• Contain spam or include links to other sites
• Are clearly off topic
• Impersonate an individual or organisation, are fraudulent, defamatory of any person, threatening or invasive of another’s privacy or otherwise illegal
• Are trolling or threatening
• Promote, advertise or solicit the sale of any goods or services

You grant us a non-exclusive, royalty-free, perpetual, worldwide licence to republish any material you submit to us, without limitation, in any format.